Nuclear GLI1 expression was observed in 26/43 (60%) ErbB2-negative tumor samples and 7/8 (88%) ErbB2-positive tumor samples, and the mean percentage of cells with nuclear GLI1 staining was 37 and 55%, respectively. Here, ERBB2 is linked to neoplasm.